Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Neck disc study cancelled before it began

NCT ID NCT05880823

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to collect real-world information on the safety and effectiveness of the Synergy Disc, a device used to treat degenerative disc disease in the neck. It planned to look at past and future patients who received the disc. However, the study was withdrawn before enrolling any participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Expected to start

Apr 2024

An estimate. Start dates often move.

Finished

Apr 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The patients for this study will be recruited from the physician's practice.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 21 or above at the time of the surgery. * Have had (retrospective cohort) or the decision has been made to have (prospective cohort) the Synergy Disc implanted * Skeletally mature patients for reconstruction of the disc from C3-C7 following a single or multiple level discectomy for intractable radiculopathy * Intractable radiculopathy and/or myelopathy with at least one of the following producing symptomatic nerve root and/or spinal cord compression: * herniated disc and/or osteophyte formation * Symptomatic nerve root and/or spinal cord compression documented by patient history (arm or neck pain and/or neurologic deficit) and imaging (CT, MRI, x-rays, etc.) * Failed a minimum of 6 weeks conservative treatment * Written informed consent given by subject. Exclusion Criteria: * Exclusion Criteria: All answers must be NO to be eligible for the study. * Moderate to advanced spondylosis * Diagnosis of osteoporosis * Active systemic infection or infection at the operative site * Pregnancy * Marked cervical instability on lateral, coronal, or flexion/extension radiographs * Cervical spine condition other than symptomatic cervical disc disease requiring surgical treatment at the involved level * Severe pathology of the facet joints of the involved vertebral bodies * Previous diagnosis of osteopenia or osteomalacia * More than one immobile vertebral level between C1 and T1 from any cause * Morbid obesity * Vulnerable person (pregnant patients, emergency cases, children, prisoners and people without mental capacity)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical degenerative disc disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Neurochirurgie am Gasteig

    Munich, Bavaria, 81669, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.